Proinflammatory cytokine TNFα promotes HPV-associated oral carcinogenesis by increasing cancer stemness

Abstract

High-risk human papillomaviruses (HPVs) are involved in the development of several human cancers, including oropharyngeal squamous cell carcinomas. However, many studies have demonstrated that HPV alone is not sufficient for the oncogenic transformation of normal human epithelial cells, indicating that additional cofactors are required for the oncogenic conversion of HPV-infected cells. Inasmuch as chronic inflammation is also closely associated with carcinogenesis, we investigated the effect of chronic exposure to tumor necrosis factor α (TNFα), the major proinflammatory cytokine, on oncogenesis in two immortalized oral keratinocyte cell lines, namely, HPV16-immortalized and human telomerase reverse transcriptase (hTERT)-immortalized cells. TNFα treatment led to the acquisition of malignant growth properties in HPV16-immortalized cells, such as (1) calcium resistance, (2) anchorage independence, and (3) increased cell proliferation in vivo. Moreover, TNFα increased the cancer stem cell-like population and stemness phenotype in HPV16-immortalized cells. However, such transforming effects were not observed in hTERT-immortalized cells, suggesting an HPV-specific role in TNFα-promoted oncogenesis. We also generated hTERT-immortalized cells that express HPV16 E6 and E7. Chronic TNFα exposure successfully induced the malignant growth and stemness phenotype in the E6-expressing cells but not in the control and E7-expressing cells. We further demonstrated that HPV16 E6 played a key role in TNFα-induced cancer stemness via suppression of the stemness-inhibiting microRNAs miR-203 and miR-200c. Overexpression of miR-203 and miR-200c suppressed cancer stemness in TNFα-treated HPV16-immortalized cells. Overall, our study suggests that chronic inflammation promotes cancer stemness in HPV-infected cells, thereby promoting HPV-associated oral carcinogenesis.

References

[1] Meanwell CA. The epidemiology of human papillomavirus infection in relation to cervical cancer. Cancer Surv., 1988, 7: 481-497.

[2] Smith EM, . Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J. Natl Cancer Inst., 2004, 96: 449-455.

[3] Mork J, . Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 2001, 344: 1125-1131.

[4] Herrero R, . Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J. Natl Cancer Inst., 2003, 95: 1772-1783.

[5] Hansson BG, . Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol., 2009, 125: 1337-1344.

[6] Mirghani H, Amen F, Moreau F, St Guily JL. Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma?. Oral. Oncol., 2015, 51: 229-236.

[7] Woodworth CD, Doniger J, Dipaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical-carcinoma. J. Virol., 1989, 63: 159-164.

[8] Park NH, . Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis, 1991, 12: 1627-1631.

[9] Shin KH, Min BM, Cherrick HM, Park NH. Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol. Carcinog., 1994, 9: 76-86.

[10] zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 1991, 184: 9-13.

[11] Lowy DR, Kirnbauer R, Schiller JT. Genital human papillomavirus infection. Proc. Natl Acad. Sci. USA, 1994, 91: 2436-2440.

[12] zur Hausen H. Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet, 1986, 2: 489-491.

[13] Gao F, Liang B, Reddy ST, Farias-Eisner R, Su X. Role of inflammation-associated microenvironment in tumorigenesis and metastasis. Curr. Cancer Drug Targets, 2014, 14: 30-45.

[14] Moore RJ, . Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis (vol 5, pg 828, 1999). Nat. Med., 1999, 5: 1087.

[15] Scott KA, . An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol. Cancer Ther., 2003, 2: 445-451.

[16] Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl Acad. Sci. USA, 1989, 86: 5974-5978.

[17] Natarajan K, Singh S, Burke TR, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc. Natl Acad. Sci. USA, 1996, 93: 9090-9095.

[18] Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature, 2004, 431: 405-406.

[19] Pikarsky E, . NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature, 2004, 431: 461-466.

[20] Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell, 2004, 6: 297-305.

[21] Yan B, . Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. Cancer Res., 2006, 66: 11565-11570.

[22] Castle PE, Giuliano AR. Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J. Natl Cancer Inst. Monogr., 2003, 2003: 29-34.

[23] Hammes LS, . Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression-clinicopathological correlation. Gynecol. Oncol., 2007, 105: 157-165.

[24] Gaiotti D, . Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway. Mol. Carcinog., 2000, 27: 97-109.

[25] Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet, 2001, 357: 539-545.

[26] Woodworth CD, McMullin E, Iglesias M, Plowman GD. Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc. Natl Acad. Sci. USA, 1995, 92: 2840-2844.

[27] Kyo S, . Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology, 1994, 200: 130-139.

[28] Soto U, . Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene, 1999, 18: 3187-3198.

[29] Shin KH, Kim RH. An updated review of oral cancer stem cells and their stemness regulation. Crit. Rev. Oncog., 2018, 23: 189-200.

[30] Chen K, Huang YH, Chen JL. Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol. Sin., 2013, 34: 732-740.

[31] Hirata N, Sekino Y, Kanda Y. Nicotine increases cancer stem cell population in MCF-7 cells. Biochem. Biophys. Res. Commun., 2010, 403: 138-143.

[32] Asiedu MK, Ingle JN, Behrens MD, Radisky DC, Knutson KL. TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res., 2011, 71: 4707-4719.

[33] Bhat-Nakshatri P, . SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer, 2010, 10

[34] Lee SH, . TNFalpha enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells. Biochem. Biophys. Res. Commun., 2012, 424: 58-64.

[35] Park NH, . Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model. Oncogene, 1995, 10: 2145-2153.

[36] Shin KH, . miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem. Biophys. Res. Commun., 2011, 404: 896-902.

[37] Paolino G, Donati M, Didona D, Mercuri SR, Cantisani C. Histology of non-melanoma skin cancers: an update. Biomedicines, 2017, 5: E71.

[38] Sun X, . MicroRNAs and cancer stem cells: the sword and the shield. Oncogene, 2014, 33: 4967-4977.

[39] Zhang Y, . miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1. Sci. Rep., 2016, 6

[40] Feng X, Wang Z, Fillmore R, Xi Y. MiR-200, a new star miRNA in human cancer. Cancer Lett., 2014, 344: 166-173.

[41] Nassar D, Blanpain C. Cancer stem cells: basic concepts and therapeutic implications. Annu. Rev. Pathol., 2016, 11: 47-76.

[42] Venkatesh V, . Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investig., 2018, 5: 5.

[43] Sethi G, Sung B, Aggarwal BB. TNF: a master switch for inflammation to cancer. Front. Biosci., 2008, 13: 5094-5107.

[44] Matsushita S, . The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res., 1999, 59: 1911-1916.

[45] Zhao P, Zhang Z. TNF-alpha promotes colon cancer cell migration and invasion by upregulating TROP-2. Oncol. Lett., 2018, 15: 3820-3827.

[46] Moore RJ, . Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat. Med., 1999, 5: 828-831.

[47] Beyne-Rauzy O, . Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells. Oncogene, 2004, 23: 7507-7516.

[48] Shin KH, Tannyhill RJ, Liu X, Park NH. Oncogenic transformation of HPV-immortalized human oral keratinocytes is associated with the genetic instability of cells. Oncogene, 1996, 12: 1089-1096.

[49] Rey O, Lee S, Park NH. Impaired nucleotide excision repair in UV-irradiated human oral keratinocytes immortalized with type 16 human papillomavirus genome. Oncogene, 1999, 18: 6997-7001.

[50] Liu X, Han S, Baluda MA, Park NH. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene, 1997, 14: 2347-2353.

[51] Shin KH, . HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and -independent pathways. Int. J. Oncol., 2006, 28: 209-215.

[52] Korkaya H, Liu S, Wicha MS. Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots. Clin. Cancer Res., 2011, 17: 6125-6129.

[53] Ghuwalewala S, . CD44(high)CD24(low) molecular signature determines the cancer stem cell and EMT phenotype in oral squamous cell carcinoma. Stem Cell Res., 2016, 16: 405-417.

[54] Yu X, . miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1. Stem Cells Dev., 2014, 23: 576-585.

[55] Brabletz S, . The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J., 2011, 30: 770-782.

[56] Sultan M, . Hide-and-seek: the interplay between cancer stem cells and the immune system. Carcinogenesis, 2017, 38: 107-118.

[57] Yugawa T, . Regulation of Notch1 gene expression by p53 in epithelial cells. Mol. Cell. Biol., 2007, 27: 3732-3742.

[58] Dickson MA, . Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol., 2000, 20: 1436-1447.

[59] Lee SH, . Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma. Oncotarget, 2016, 7: 43239-43255.